Clinical and pharmacokinetic phase I study with Cematodin® given as continuous 24-hour intravenous infusion
Mross, K., Fiebig, H.H., Bredel, W., Bankmann, Y., von Broen, I.M., Walter, N., Unger, C.Volume:
33
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(97)86032-7
Date:
September, 1997
File:
PDF, 250 KB
english, 1997